About
Technology
Issues
FAQ
Links
Official Page
Efficacy and safety of olaparib monotherapy in germline BRCA1 / 2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.